Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Impact of COVID-19 Infection on Children and Adolescents after Liver Transplantation in a Latin American Reference Center.

ALINE FALLEIROS DE FREITAS
,
RENATA PEREIRA SUSTOVICH PUGLIESE
,
FLAVIA FEIER
ORCID logo ,
IRENE KAZUE MIURA
,
VERA LUCIA BAGGIO DANESI
,
ELIENE NOVAIS OLIVEIRA
,
ADRIANA PORTA HIRSCHFELD
,
CRISTIAN BARBIERI BORGES
,
JULIANA VIEIRA LOBATO
,
GILDA PORTA
,
JOAO SEDA NETO
,
EDUARDO ANTUNES FONSECA
* ORCID logo
Version 1 : Received: 30 April 2022 / Approved: 9 May 2022 / Online: 9 May 2022 (03:59:57 CEST)

A peer-reviewed article of this Preprint also exists.

Freitas, A.F.; Pugliese, R.P.S.; Feier, F.; Miura, I.K.; Danesi, V.L.B.; Oliveira, E.N.; Hirschfeld, A.P.M.; Borges, C.B.V.; Lobato, J.V.; Porta, G.; Seda-Neto, J.; Fonseca, E.A. Impact of COVID-19 Infection on Children and Adolescents after Liver Transplantation in a Latin American Reference Center. Microorganisms 2022, 10, 1030. Freitas, A.F.; Pugliese, R.P.S.; Feier, F.; Miura, I.K.; Danesi, V.L.B.; Oliveira, E.N.; Hirschfeld, A.P.M.; Borges, C.B.V.; Lobato, J.V.; Porta, G.; Seda-Neto, J.; Fonseca, E.A. Impact of COVID-19 Infection on Children and Adolescents after Liver Transplantation in a Latin American Reference Center. Microorganisms 2022, 10, 1030.

Abstract

Background: COVID-19 infection has received the attention of the scientific community due its respiratory manifestations and association with evolution to severe acute respiratory syndrome (SARS-CoV-2). There are few studies characterizing SARS-CoV-2 in pediatric immunocompromised patients, such as liver transplanted (LT) patients.The aim of this study was to analyze the outcomes of the larger cohort of pediatric liver transplant recipients (PLTR) from a single center in Brazil who where contaminated with COVID-19 during the pandemic. Methods: Cross-sectional study. Primary outcomes: COVID-19 severity. The Cox regression method was used to determine independent predictors associated with the outcomes. Results: 74 PLTR were included. Patients were divided into two groups according to the severity of COVID-19 disease: moderate-severe COVID and asymptomatic-mild COVID. Patients categorized as moderate-severe COVID were younger (12.6 months vs. 82.1 months, p 0.03), higher prevalence of transplantation with deceased donor (50% vs. 4.3%, p 0.02) and with a higher prevalence of COVID-infected patients before 6 months after LT (75% vs. 5.7%, p 0.002). The independent predictor of COVID-19 severity identified in the multivariate analysis was COVID-19 infection < 6 months after LT (HR=0.001, 95% CI=0.001-0.67, p 0.03). Conclusion: The time interval of less than 6 months between COVID-19 infection and LT was the only predictor of disease severity in pediatric patients.

Keywords

COVID-19; pediatric liver transplantation; immunosuppression; living donor liver transplantation

Subject

Medicine and Pharmacology, Transplantation

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.